Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
Clinical trial NCT05048615 · COMPLETED
Trial details
- NCT number
- NCT05048615
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2023-01-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.